Si Sun

4.6k total citations · 1 hit paper
147 papers, 2.9k citations indexed

About

Si Sun is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Si Sun has authored 147 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 56 papers in Oncology and 40 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Si Sun's work include Lung Cancer Treatments and Mutations (21 papers), Epigenetics and DNA Methylation (13 papers) and Lung Cancer Research Studies (13 papers). Si Sun is often cited by papers focused on Lung Cancer Treatments and Mutations (21 papers), Epigenetics and DNA Methylation (13 papers) and Lung Cancer Research Studies (13 papers). Si Sun collaborates with scholars based in China, United States and France. Si Sun's co-authors include Qi Wu, Shengrong Sun, Juanjuan Li, Yang Ouyang, Jing Cai, Xiaoyu Fu, Zehua Wang, Xinyue Chen, Juanjuan Li and Jian Zhang and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Si Sun

138 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chalcone Derivatives: Role in Anticancer Therapy

2021 259 citations Si Sun, Qi Wu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Si Sun China	28	1.4k	857	737	565	319	147	2.9k
Bikul Das United States	23	1.6k 1.1×	922 1.1×	628 0.9×	332 0.6×	378 1.2×	54	3.3k
Ping Chen China	31	2.1k 1.5×	838 1.0×	728 1.0×	390 0.7×	194 0.6×	125	3.3k
Zhe Wang China	31	1.6k 1.1×	530 0.6×	1000 1.4×	528 0.9×	244 0.8×	198	3.0k
Vijay Pandey China	30	1.4k 1.0×	658 0.8×	706 1.0×	226 0.4×	281 0.9×	105	2.5k
Kenneth W. Yip Canada	23	1.5k 1.1×	522 0.6×	697 0.9×	290 0.5×	251 0.8×	40	2.7k
Yate‐Ching Yuan United States	31	1.7k 1.2×	889 1.0×	694 0.9×	336 0.6×	303 0.9×	81	2.9k
Xiangdong Cheng China	28	1.8k 1.2×	1.0k 1.2×	819 1.1×	572 1.0×	208 0.7×	133	3.1k
Venkateshwar G. Keshamouni United States	31	2.0k 1.4×	800 0.9×	698 0.9×	476 0.8×	627 2.0×	49	3.5k
Qing Xu China	28	1.3k 0.9×	415 0.5×	714 1.0×	286 0.5×	244 0.8×	102	2.7k
Ana Bela Sarmento‐Ribeiro Portugal	30	1.5k 1.1×	729 0.9×	743 1.0×	351 0.6×	302 0.9×	130	3.2k

Countries citing papers authored by Si Sun

Since Specialization

Citations

This map shows the geographic impact of Si Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Si Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Si Sun more than expected).

Fields of papers citing papers by Si Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Si Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Si Sun. The network helps show where Si Sun may publish in the future.

Co-authorship network of co-authors of Si Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Si Sun. A scholar is included among the top collaborators of Si Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Si Sun. Si Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Jintao & Si Sun. (2025). Adept or Inept? Examining the Chinese Government's Social Media Crisis Response During the Zhengzhou Rainstorm. Journal of Contingencies and Crisis Management. 33(1).

Liu, Pan, Guoqing Li, Wenwen Wang, et al.. (2025). LEF1 confers resistance to DNA-damaging chemotherapies through upregulation of PARP1 and NUMA1 in ovarian cancer. Oncogene. 44(43). 4130–4144.

Li, Qin, et al.. (2025). In Situ Self‐Assembly of Artificial Topological Nanostructures Enhances In Vivo Efficacy of PCSK9 Inhibitory Peptides. Angewandte Chemie International Edition. 64(17). e202502559–e202502559. 2 indexed citations

Gao, Yumei, Xiaoman Wang, Xiaoli Liu, et al.. (2025). CBX2 promotes cervical cancer cell proliferation and resistance to DNA-damaging treatment via maintaining cancer stemness. Journal of Biological Chemistry. 301(2). 108170–108170. 1 indexed citations

Zhang, Xin, Wenyue Yang, Zhen Wang, et al.. (2024). Plasma extracellular vesicle long RNA profiling identifies a predictive signature for immunochemotherapy efficacy in lung squamous cell carcinoma. Frontiers in Immunology. 15. 1421604–1421604. 1 indexed citations

Sun, Si, et al.. (2024). Navigating and Overcoming Barriers to Digital Energy Transition for Carbon Neutrality in China. Energies. 17(23). 5888–5888. 4 indexed citations

Huang, Lin, et al.. (2024). Glutamine metabolism prognostic index predicts tumour microenvironment characteristics and therapeutic efficacy in ovarian cancer. Journal of Cellular and Molecular Medicine. 28(7). e18198–e18198. 4 indexed citations

Lin, Ying, Bo Yu, Hongyu Zhang, et al.. (2023). Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor. Journal of Cancer Research and Clinical Oncology. 149(11). 8663–8671. 20 indexed citations

Xu, Yanjun, Zhiyu Huang, Jianhua Chang, et al.. (2023). Safety and efficacy of atezolizumab in Chinese patients with previously treated locally advanced or metastatic non-small cell lung cancer: An open-label, single-arm, multicenter study. Lung Cancer. 183. 107288–107288. 2 indexed citations

10.

Zhang, Yao, Ying Lin, Chang Liu, et al.. (2023). Clinicopathological features, treatment modalities, and prognosis of esophageal neuroendocrine carcinoma: A single‐center retrospective study. Journal of Digestive Diseases. 24(8-9). 472–479. 3 indexed citations

11.

Cheng, Ying, Qing Zhou, Baohui Han, et al.. (2023). NEPTUNE China cohort: First-line durvalumab plus tremelimumab in Chinese patients with metastatic non-small-cell lung cancer. Lung Cancer. 178. 87–95. 6 indexed citations

12.

Sun, Si, et al.. (2023). Breast cancer cell-derived exosome-delivered microRNA-155 targets UBQLN1 in adipocytes and facilitates cancer cachexia-related fat loss. Human Molecular Genetics. 32(13). 2219–2228. 15 indexed citations

13.

Mao, Weipu, Si Sun, Qiang Hu, et al.. (2022). Characterization of an Autophagy-Immune Related Genes Score Signature and Prognostic Model and its Correlation with Immune Response for Bladder Cancer. SHILAP Revista de lepidopterología. 3 indexed citations

14.

Li, Guoqing, Xiaoqing Yi, Jing Cai, et al.. (2022). Tumour-derived exosomal piR-25783 promotes omental metastasis of ovarian carcinoma by inducing the fibroblast to myofibroblast transition. Oncogene. 42(6). 421–433. 25 indexed citations

15.

Wu, Qi, et al.. (2021). Extracellular vesicles and immunogenic stress in cancer. Cell Death and Disease. 12(10). 894–894. 43 indexed citations

16.

Sun, Si, Weipu Mao, Lei Zhang, et al.. (2021). Development and Validation of Prognostic Nomogram for Young Patients with Kidney Cancer. International Journal of General Medicine. Volume 14. 5091–5103. 6 indexed citations

17.

Li, Bei, Rongxin Geng, Qi Wu, et al.. (2020). Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer. Frontiers in Oncology. 10. 333–333. 24 indexed citations

18.

Li, Bei, Qian Yang, Zhiyu Li, et al.. (2020). Expression of Monocarboxylate Transporter 1 in Immunosuppressive Macrophages Is Associated With the Poor Prognosis in Breast Cancer. Frontiers in Oncology. 10. 574787–574787. 22 indexed citations

19.

Sun, Si, Zhihuang Hu, Shenglin Huang, et al.. (2019). REG4 is an indicator for KRAS mutant lung adenocarcinoma with TTF-1 low expression. Journal of Cancer Research and Clinical Oncology. 145(9). 2273–2283. 8 indexed citations

20.

Li, Ting, Biyun Wang, Zhonghua Wang, et al.. (2015). Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial. PLoS ONE. 10(7). e0133133–e0133133. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact